Andrew Martin

Professor Andrew Martin is Principal Research Fellow in Biostatistics at the NHMRC Clinical Trials Centre, University of Sydney, and Associate Professor Biostatistics in the Faculty of Medicine and Health. With over 20 years' experience in clinical trials research gained from senior roles in research-based pharmaceutical organisations and the University of Sydney, he specialises in the application of optimal study designs and analysis methods to the development and evaluation of health interventions across all phases of development. This includes incorporating quality of life and economic evaluations within clinical trials, and employing decision analytic techniques to model longer-term benefits and costs of interventions.

Professor Martin provides statistical leadership to clinical trial networks in various disease areas, including the design, conduct, analysis, and reporting of clinical trials. He is responsible for content development, coordination, and teaching of postgraduate units in decision analysis and controlled clinical trials at the University of Sydney, as well as courses and workshops in clinical trial concept development and statistical methods. He serves as Biostatistical Editor for Therapeutic Advances in Medical Oncology. Key publications include 'Protocol for the Lactoferrin Infant Feeding Trial (LIFT): a randomised trial' (BMJ Open, 2018), 'BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy' (BMC Cancer, 2015), 'ENZA-p trial protocol: a randomized phase II trial' (BJU International, 2021), 'Effect Sizes Hypothesized and Observed in Contemporary Phase III Cancer Clinical Trials' (JNCI Cancer Spectrum, 2018), 'Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy' (JNCI Cancer Spectrum, 2020), and 'Challenges of estimating treatment effects after a positive interim analysis' (European Journal of Cancer, 2024). Professional Email: a.martin@sydney.edu.au